The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Enhanced Regimen ( CLEAR-ER ) trial demonstrated safety of recombinant tissue-type plasminogen activator ( r-tPA ) plus eptifibatide in acute ischemic stroke ( AIS ) .